Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Neoadjuvant Chemotherapy on Exercise Capacity and Outcome Following Upper Gastrointestinal Cancer Surgery.

NCT01325883 is registered in ClinicalTrials.gov with Liverpool University Hospitals NHS Foundation Trust as lead sponsor.

NCT NCT01325883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01325883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Neoadjuvant Chemotherapy on Exercise Capacity and Outcome Following Upper Gastrointestinal Cancer Surgery.
Lead sponsor
Liverpool University Hospitals NHS Foundation Trust
Phase
Observational
Overall status
Completed
Start date
April 30, 2011
Completion date
January 31, 2016
Enrollment
253 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tumor of esophagus, stomach and duodenum